1. Home
  2. ANIK vs III Comparison

ANIK vs III Comparison

Compare ANIK & III Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$14.72

Market Cap

198.9M

Sector

Health Care

ML Signal

HOLD

Logo Information Services Group Inc.

III

Information Services Group Inc.

HOLD

Current Price

$4.28

Market Cap

203.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANIK
III
Founded
1983
2006
Country
United States
United States
Employees
N/A
1500
Industry
Medical/Dental Instruments
Professional Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
198.9M
203.8M
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
ANIK
III
Price
$14.72
$4.28
Analyst Decision
Buy
Buy
Analyst Count
1
1
Target Price
$17.00
$5.50
AVG Volume (30 Days)
54.5K
234.6K
Earning Date
04-29-2026
05-07-2026
Dividend Yield
N/A
4.46%
EPS Growth
80.16
216.67
EPS
N/A
0.05
Revenue
$112,819,000.00
$192,745,000.00
Revenue This Year
$5.98
$3.85
Revenue Next Year
$7.42
$4.34
P/E Ratio
N/A
$85.80
Revenue Growth
N/A
4.51
52 Week Low
$7.90
$3.74
52 Week High
$16.24
$6.45

Technical Indicators

Market Signals
Indicator
ANIK
III
Relative Strength Index (RSI) 52.01 49.55
Support Level $13.91 $3.95
Resistance Level $15.01 $4.37
Average True Range (ATR) 0.53 0.14
MACD 0.01 -0.03
Stochastic Oscillator 53.27 41.12

Price Performance

Historical Comparison
ANIK
III

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

About III Information Services Group Inc.

Information Services Group Inc is an AI-centered technology research and advisory firm providing digital transformation and technology advisory services that help organizations optimize performance, reduce costs, and accelerate innovation. The Company's expertise includes sourcing advisory, cloud and data analytics, managed governance and risk services, network and software advisory, technology strategy and operations design, change management, and market intelligence, serving both private- and public-sector clients globally. It operates in one segment, fact-based sourcing advisory services, and operates principally in the Americas, with generate maximum revenue in Europe and the Asia Pacific.

Share on Social Networks: